Study objective: To compare the safety of salmeterol xinafoate or placebo added to usual asthma care. Design: A 28-week, randomized, double-blind, placebo-controlled, observational study.

A small proportion of veterans who went from a metered-dose inhaler to a dry-powder inhaler had to revert to the metered-dose ...

Salmeterol (as xinafoate) 50mcg/inh; dry pwd for inhalation; device with drug in blisters. Serevent Diskus is supplied as a disposable teal green plastic inhaler containing a foil blister strip ...

Objective: To compare the efficacy and tolerability of a salmeterol/fluticasone propionate (FP) combination product (50/100µg twice daily) with budesonide (BUD) at a four-fold higher microgram ...

METHODS The aim of this study was to compare, in a double blind, three way, crossover study, the effects of the addition of salmeterol 50 μg bd, salmeterol 100 μg bd, and salbutamol 200 μg qds in ...

BACKGROUND The objective of this multicentre, randomised, double blind, parallel group study was to compare the efficacy and safety of the addition of salmeterol with that of doubling the dose of ...

Fluticasone propionate, salmeterol (as xinafoate) 55mcg/14mcg, 113mcg/14mcg, 232mcg/14mcg; per actuation; dry pwd for oral inh with a dose counter; contains lactose. Increased risk of asthma ...

Combination meds with an ICS and LABA option to relax and open airways, like Advair (fluticasone with salmeterol) Long-acting muscarinic agonists (LAMA) drugs, including Spiriva Respimat (tiotropium ...

As of 2013, the beta2-agonists salbutamol, formoterol and salmeterol are allowed by inhalation in therapeutic doses, and no longer require athletes to acquire a therapeutic use exemption. To ...